Challenges and developments in tandem mass spectrometry based clinical metabolomics.
about
Spectral deconvolution for gas chromatography mass spectrometry-based metabolomics: current status and future perspectivesThe LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany.Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MSIntegration of Genome-Wide SNP Data and Gene-Expression Profiles Reveals Six Novel Loci and Regulatory Mechanisms for Amino Acids and Acylcarnitines in Whole Blood.Advanced Multidimensional Separations in Mass Spectrometry: Navigating the Big Data Deluge.Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry dataDealing with the unknown: metabolomics and metabolite atlases.Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation.Nutritional metabolomics: progress in addressing complexity in diet and health.Mass spectrometry-based technologies for high-throughput metabolomics.Serum amino acid profiles and their alterations in colorectal cancer.Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate modelAn Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue.Screening for inherited metabolic diseases using gas chromatography-tandem mass spectrometry (GC-MS/MS) in Sichuan, China.Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicineThe metabolic signature associated with the Western dietary pattern: a cross-sectional study.Photodissociation mass spectrometry: new tools for characterization of biological molecules.Advances in mass spectrometry applied to pharmaceutical metabolomics.Fast liquid chromatography combined with mass spectrometry for the analysis of metabolites and proteins in human body fluids.Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies.Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry.Liquid chromatography tandem mass spectrometry in the clinical laboratory.Stability of energy metabolites-An often overlooked issue in metabolomics studies: A review.Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS.The LIFE Child study: a population-based perinatal and pediatric cohort in Germany.Stability of metabolites in dried blood spots stored at different temperatures over a 2-year period.Systematic Assessment of Seven Solvent and Solid-Phase Extraction Methods for Metabolomics Analysis of Human Plasma by LC-MS.Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma.Feline urine metabolomic signature: characterization of low-molecular-weight substances in urine from domestic cats.Screening of Inherited Metabolic Disorders in Infants with Infantile Spasms.Hierarchical cluster analysis of technical replicates to identify interferents in untargeted mass spectrometry metabolomics.
P2860
Q26825767-23D69CC8-ACDF-4E9A-99D3-E59EE36FAEF2Q30406451-BC6A4679-41D8-4109-BCCC-7ABC7BF6F785Q30536390-94F70BDE-6BF3-4690-8214-AEE0E9AB355EQ30996686-A505167B-737B-417A-B6ED-F4205912C3B0Q31108309-91B75B77-1948-4A96-A716-BDB187CAF5BFQ31172638-312FB6FF-6B41-4166-9053-5D40EBB55D26Q33349044-BDA09E5E-3BD3-44CA-BF93-46DFE662CD23Q33602704-BF27EE5F-6562-4E78-BFBE-3F1911B860AEQ33650227-14970F94-7B39-43A6-9AE3-14EB35F37602Q33748840-810AB71B-B710-4EEF-9AE2-E7A03187C25EQ34660782-87419A4E-7DE1-4185-86B8-63A45054B960Q34724200-436FFD36-AC16-48F3-AC9B-8ACAAF3323D6Q35741264-7A7575ED-9310-4E07-803C-922209536CD1Q36077253-B3021059-6B79-41DC-8B77-5C18A77C4B6FQ36124015-5EC215C9-7DE9-443D-A717-569CF5BBEAE9Q37346519-FCC79D08-1752-4C7E-BFDF-FF98127F9BB4Q37418050-F46B3EFF-7CFD-47D5-93EE-38D0E7BF2496Q37666151-3EA5818B-DC33-4596-86B6-D431554ECED1Q37812335-29F56B3E-E5C6-4B92-9C54-E6B3A11CB3D3Q37831178-85954D7E-72EA-476A-8CD7-7D6DA1BEB898Q37850751-A7D21842-B14A-4C8C-A4A2-6FE548F44BEFQ38009236-97ECD6BD-BB60-429A-BBC7-E521DA137DF2Q38260022-B2AEC9B2-19D4-4384-BB25-35F0833F0537Q38469946-85CB94AE-40D3-450B-9DA1-345A31DD132AQ38808459-81E20821-8E19-4153-ABB5-16D985B863DDQ38987782-C43F3412-7299-4869-9976-76C9D7E1CE9BQ39397563-97259BCC-05E5-4868-B5AA-384CA5543FC2Q39615620-5A487C8D-C3A3-4C29-AEF9-1671E24A55DDQ40634575-CF157868-B9AD-45CC-BA17-E6660D2A0634Q47224149-E20BF685-29E3-4E26-B27A-9585D84E35E8Q48449484-B639B276-6862-4A66-8A85-227BD0EA7F64Q52313333-A5E1C045-C5B8-4866-8B96-77C42CDD230F
P2860
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
@en
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
@nl
type
label
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
@en
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
@nl
prefLabel
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
@en
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
@nl
P2093
P50
P1476
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
@en
P2093
Kristin Bresler
Linda Kortz
Mathias Brügel
Romy Brauer
P304
P356
10.1016/J.MCE.2008.10.013
P577
2008-10-19T00:00:00Z